Spontaneous EAE in TCR transgenic SJL/J mice: course of disease
| Mice (gender) | RR (n) | Progressive (n) | |
| With full remission | With partial remission | ||
| % | % | % | |
| TCR1640 (f) | 71.4 (5/7) | 14.3 (1/7) | 14.3 (1/7) |
| TCR1640 (m) | 35.3 (6/17) | 11.7 (2/17) | 53 (9/17) |
| TCR1640 × IgHMOG (f) | 43.7 (7/16) | 25.0 (4/16) | 31.2 (5/16) |
| TCR1640 × IgHMOG (m) | 6.2 (1/16) | 25.0 (4/16) | 68.8 (11/16) |
| rMOG imm. SJL/J (f) | 10.0 (1/10) | 70.0 (7/10) | 20 (2/10) |
| Mice (gender) | RR (n) | Progressive (n) | |
| With full remission | With partial remission | ||
| TCR1640 (f) | 71.4 (5/7) | 14.3 (1/7) | 14.3 (1/7) |
| TCR1640 (m) | 35.3 (6/17) | 11.7 (2/17) | 53 (9/17) |
| TCR1640 × IgHMOG (f) | 43.7 (7/16) | 25.0 (4/16) | 31.2 (5/16) |
| TCR1640 × IgHMOG (m) | 6.2 (1/16) | 25.0 (4/16) | 68.8 (11/16) |
| rMOG imm. SJL/J (f) | 10.0 (1/10) | 70.0 (7/10) | 20 (2/10) |
f, female; m, male; imm., immunized.